Directed new share issue in Bonesupport Holding AB (SE) — SEK 378 million

Carnegie acted as joint bookrunner in the directed new share issue of 10,500,000 new shares at a subscription price of SEK 36 per share. BONESUPPORT is a Scandinavian orthobiologics company that develops and markets CERAMENT®, an innovative range of radiopaque injectable osteoconductive and drug-eluting bioceramic products that have a proven ability to heal defects by remodeling to host bone in six to twelve months. May 2020.